All tenders
75N93022C00055
Neutralizing Antibody Vaccine for Pandemic Coronaviruses
National Institutes of Health · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75N93022C00055
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- Neutralizing Antibody Vaccine for Pandemic Coronaviruses
- Source
- USASpending (Federal)
- Source ID
- usa-75N93022C00055
Details
- Location
- United States
Summary
NIH-funded research project at Duke University focusing on developing a vaccine capable of neutralizing pandemic and pre-emergent coronavirus strains, with potential broad-spectrum protection.
Description
"ADVANCED DEVELOPMENT OF A NEUTRALIZING ANTIBODY VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES" Awarded to: DUKE UNIVERSITY Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2022/09/19 12:00:00 AM UTC
- Closing date
- 2028/05/31 12:00:00 AM UTC
Estimated value
$18.2M – $2.5M USD
Classification
Normalized category
Healthcare & Medical